Abstract
Purpose
We aimed to evaluate the serum prolidase activity (SPA), malondialdehyde (MDA), and catalase levels in patients with pseudoexfoliation (PEX) syndrome.
Method
Thirty-four patients with PEX syndrome and thirty-eight age- and gender-matched healthy subjects were included in this prospective clinical study. Each participant underwent full ophthalmologic examination. The SPA, serum MDA, and catalase levels were measured and compared between the patients with PEX syndrome and healthy subjects.
Results
The SPA was significantly lower in patients with PEX syndrome compared to healthy controls (14.1 ± 7.1 vs. 30.1 ± 4.3 ng/ml; p = 0.001). The mean serum MDA values the of PEX syndrome and control groups were comparable (28.7 ± 5.7 vs. 30.4 ± 5.3 nmol/ml, respectively; p = 0.185). The mean serum catalase level tended to be lower in the PEX group compared to healthy controls (0.12 ± 0.02 vs. 0.21 ± 0.05 k/ml, respectively; p = 0.077).
Conclusion
Our findings suggest that the SPA was significantly lower in patients with PEX syndrome compared to healthy controls. Thus, prolidase may have a role in the pathogenesis of the PEX syndrome.
Similar content being viewed by others
References
Schlötz-Schrehardt UM, Koca MR, Naumann GOH, Volkholz H (1992) Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 110:1752–1756
Streeten BW, Li ZY, Wallace RN, Eagle RCJ, Keshegehehian AA (1992) Pseudoexfoliative fibrilliopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 110:1757–1762
Lindberg JG (1917) Clinical studies of depigmentation of the pupillary margin and transillumination of the iris in case of senil cataract and also in normal eyes in the aged. Diss Helsingfors Univ
Naumann G, Schlötzer-Schrehardt U, Küchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmol 105:951–968
Ritch R (2001) Exfoliation syndrome. Curr Opin Ophthalmol 12:124–130
Ritch R (2014) Ocular and systemic manifestation of exfoliation syndrome. J Glaucoma 23:1–8
Yüksel N, Karabaş VL, Arslan A, Demirci A, Çağlar Y (2001) Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108:1043–1049
Schlötz-Schrehardt U, Koca MR, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141:921–937
Kusano C, Ferrari B (2008) Total antioxidant capacity: a biomarker in biomadical and nutritional studies. J Cell Mol Biol 7:1–15
Chen J, Zeng L, Xia T et al (2015) Toward a biomarker of oxidative stress: A fluorescent probe for exogenous and endogenous malondialdehyde living cells. Anal Chem 87:8052–8056
Glorieux C, Zamocky M, Sandoval JM, Verrax J, Calderon PB (2015) Regulation of catalase expression in healthy and cancerous cells. Free Radic Biol Med 87:84–97
Wu G, Bazer FW, Burghardt RC et al (2011) Prolin and hydroxyprolin metabolism: implication for animal and human nutrition. Amino Acids 40:1053–1063
Kurien BT, Patel NC, Porter AC (2006) Prolidase deficiency and the biochemical assays used in its diagnosis. Anal Biochem 349:165–175
Gartaganis SP, Georgakopoulos CD, Mela EK et al (2002) Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res 34:165–171
Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO (2003) Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open angle glaucoma. Invest Ophthalmol Vis Sci 44:1117–1125
Aebi H (1974) Catalase. In: Bergmeyer U (ed) Methods of enzymatic analysis. Academic Press, New York and London, pp 673–677
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421
Totan Y, Çekiç O, Borazan M, Uz E, Sogut S, Akyol O (2001) Plasma malondialdehyde and nitric oxide levels in age related macualar degeneration. Br J Ophtalmol 85:1426–1428
Bhuyan KC, Bhuyan DK, Podos SM (1986) Lipid peroxidation in cataract of the human. Life Sci 38:1463–1471
Erdurmuş M, Yağcı R, Atış Ö, Karadağ R, Akbaş A, Hepsen IF (2011) Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res 36:713–718
Yagci R, Gurel A, Ersoz I et al (2006) Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr Eye Res 31:1029–1032
Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AG (2008) Prooxidant antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Ophthalmol 246:1477–1483
Yılmaz A, Adigüzel U, Tamer L et al (2005) Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol 33:63–66
Surazynski A, Miltyk W, Palka J, Phang JM (2008) Prolidase dependent regulation of collagen biosynthesis. Amino Acids 35:731–738
Jackson SH, Dennis AW, Greenberg M (1975) Iminodipeptiduria: a genetic defect in recycling collagen: a metod for determining prolidase in erythrocytes. Can Med Assoc J 113:759–763
Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H, Sorsa T (2005) Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open angle glaucoma, exfoliation syndrome, and axfoliation glaucoma. J Glaucoma 14:64–69
Verma AK, Raj J, Sharma V, Singh TB, Srivastava S, Srivastava R (2015) Plasma prolidase activity and oxidative stress with parkinson’s disease. Park Dis. doi:10.1155/2015/598028
Akçakoyun M, Pala S, Esen O et al (2010) Dilatation of the ascending aort is associated with low serum prolidase activity. Tohoku J Exp Med 220:273–277
Kıratlı H, Satılıs M (1998) Prolidase deficiency associated with pathologic myopia. Ophthalmic Genet 19:49–53
Gomes I, Xiong W, Miki T, Rosner MR (1999) A prolin and glutamin rich protein promots apoptosis in neuronal cells. J Neurochem 73:612–622
Berlau J, Lorenz P, Beck R (2001) Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 239:743–746
Ringvold A, Husdy G (1973) Pseudoexfoliation material an amyloid like substance. Exp Eye Res 17:289–299
Ringvold A, Husdy G, Pettersen S (1989) Electrophoretic study of proteins associated with pseudoexfoliation syndrome. Acta Ophthalmol (Copenh) 67:724–726
Gottanka J, Flügel-Koch C, Martus P, Johnson DH, Lütjen-Drecoll E (1997) Correlation of pseudoexfoliation material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 38:2435–2446
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
The study adhered to the tenets of the Declaration of Helsinki. The Institutional Review Board of the Dumlupinar University School of Medicine approved the study protocol.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
This manuscript has not been previously published and is not under consideration for publication elsewhere. The authors do not have any financial or proprietary interest in a product, method, or material mentioned in the manuscript.
Rights and permissions
About this article
Cite this article
Tetikoğlu, M., Sağdik, H.M., Aktas, S. et al. Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 254, 1339–1343 (2016). https://doi.org/10.1007/s00417-016-3338-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3338-6